InMed Pharmaceuticals (FRA:MWG) Float Percentage Of Total Shares Outstanding: 99.58% (As of Jul. 11, 2026)


FRA:MWG InMed Pharmaceuticals Inc FRA:MWG
29 GF Score
Price €1.40
GF Value €0.78
! 4 Warning Signs
View Full Analysis

What is InMed Pharmaceuticals Float Percentage Of Total Shares Outstanding?

InMed Pharmaceuticals FRA:MWG +0.72% 29 Float Percentage Of Total Shares Outstanding is 99.58% as of Jul. 11, 2026. GuruFocus rates FRA:MWG with a GF Score™ of 29/100 and a GF Value™ of €0.78. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InMed Pharmaceuticals's float shares is 5.32 Mil. InMed Pharmaceuticals's total shares outstanding is 5.34 Mil. InMed Pharmaceuticals's float percentage of total shares outstanding is 99.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InMed Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InMed Pharmaceuticals's Institutional Ownership is 3.93%.

FRA:MWG
29GF Score
InMed Pharmaceuticals Inc FRA:MWG
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InMed Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

InMed Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.32/5.34
=99.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.58% mean?
InMed Pharmaceuticals (FRA:MWG) has a Float Percentage Of Total Shares Outstanding of 99.58% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on InMed Pharmaceuticals and its competitors.
Is InMed Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
InMed Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 99.58%. Overall, InMed Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does InMed Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to SNOA and CVSI?
InMed Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 99.58% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on InMed Pharmaceuticals and its competitors. InMed Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 99.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InMed Pharmaceuticals stock overvalued right now?
InMed Pharmaceuticals (FRA:MWG) has a current Float Percentage Of Total Shares Outstanding of 99.58%. The stock's GF Value™ is €0.78, compared to a current price of €1.40 — trading 79.5% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.58%. InMed Pharmaceuticals' overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For InMed Pharmaceuticals (FRA:MWG), the current Float Percentage Of Total Shares Outstanding is 99.58% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InMed Pharmaceuticals (FRA:MWG) Overvalued in 2026?

Based on GuruFocus' analysis, InMed Pharmaceuticals stock appears to be overvalued. The current stock price of €1.40 is trading 79.5% above its estimated GF Value™ of €0.78.

Key valuation signals for FRA:MWG:

  • Float Percentage Of Total Shares Outstanding: 99.58%
  • GF Value™: €0.78 vs. price of €1.40 (79.5% above fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the FRA:MWG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InMed Pharmaceuticals Business Description

Other Exchanges INM:USA
Address 885 West Georgia Street, Suite 1445, Vancouver, BC, CAN, V6C 3E8
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
29GF Score

Get the complete analysis for FRA:MWG

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.40
Price
€0.78
GF Value